Atlas Trials

A First-In-Human Study of LY3839840 in Healthy Participants

Clinical trial NCT06153355 · COMPLETED

Trial details

NCT number
NCT06153355
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2023-12-04
Primary completion
2025-05-22
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.